Photo by nci from unsplash
IMH. No difference in survival or time to last clinical follow-up was observed between those who underwent surgery and those who did not (53.2 vs 61.1 months; P 1⁄4 .799).… Click to show full abstract
IMH. No difference in survival or time to last clinical follow-up was observed between those who underwent surgery and those who did not (53.2 vs 61.1 months; P 1⁄4 .799). Among the type B IMH group, all 18 were initially managed expectantly, with 6 undergoing eventual surgical or endovascular intervention. No emergent repairs of a type B IMH were performed. No difference in survival or time to last clinical follow-up was observed between those who underwent surgery and those who did not (31.9 vs 39.0 months; P 1⁄4 .759). Conclusions: Unlike type A dissection, type A IMHmay be safely treated with medical management in selected patients similar to type B IMH without the need for mandatory emergent surgical intervention.
Journal Title: Journal of Vascular Surgery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!